MILLER; Duncan Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for MILLER; Duncan Charles.The latest application filed is for "isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity".

Company Profile

8.7.12

MILLER; Duncan Charles - Newcastle upon Tyne GB
Miller; Duncan Charles - Sandwich GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20220106287 - CHESSARI; Gianni ; et al.	2022-04-07
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 11,261,171 - Chessari , et al. March 1, 2	2022-03-01
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20210276984 - CHESSARI; Gianni ; et al.	2021-09-09
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,981,898 - Chessari , et al. April 20, 2	2021-04-20
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20200247789 - Kind Code	2020-08-06
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20200079761 - CHESSARI; Gianni ; et al.	2020-03-12
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,544,132 - Chessari , et al. Ja	2020-01-28
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 10,526,311 - Chessari , et al. J	2020-01-07
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20190055215 - CHESSARI; Gianni ; et al.	2019-02-21
Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20190016708 - CHESSARI; Gianni ; et al.	2019-01-17
(4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators Grant 9,079,878 - Bagal , et al. July 14, 2	2015-07-14
Chemical compounds Grant 8,927,587 - Bagal , et al. January 6, 2	2015-01-06
(4-Phenylimidazol-2-yl) Ethylamine Derivatives Useful As Sodium Channel Modulators App 20140296313 - Bagal; Sharanjeet Kaur ; et al.	2014-10-02
Chemical Compounds App 20130274243 - Bagal; Sharanjeet Kaur ; et al.	2013-10-17
Salt form of dopamine agonist Grant 7,498,329 - Green , et al. March 3, 2	2009-03-03
New Amino Derivatives and Their Use as Pharmaceuticals App 20090005354 - Allerton; Charlotte Moira Norfor ; et al.	2009-01-01
Novel salt form of a dopamine agonist App 20060183740 - Green; Stuart Peter ; et al.	2006-08-17
New aminopyridine derivatives and their use as pharmaceuticals App 20050288270 - Allerton, Charlotte Moira Norfor ; et al.	2005-12-29
New indazole and indolone derivatives and their use pharmaceuticals App 20050267096 - Allerton, Charlotte Moira Norfor ; et al.	2005-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.